Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04745689 |
| Title | Study of AZD2811 + Durvalumab in ES-SCLC (TAZMAN) |
| Acronym | TAZMAN |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | AstraZeneca |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | POL | ESP |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Grand Rapids | Michigan | 49503 | United States | Details | |
| Research Site | Bydgoszcz | 85-796 | Poland | Details | ||
| Research Site | Olsztyn | 10-357 | Poland | Details | ||
| Research Site | Poznan | 60-693 | Poland | Details | ||
| Research Site | Cheongju-si | 28644 | South Korea | Details | ||
| Research Site | Jinju | 52727 | South Korea | Details | ||
| Research Site | Seoul | 03722 | South Korea | Details | ||
| Research Site | Seoul | 05505 | South Korea | Details | ||
| Research Site | Seoul | 06351 | South Korea | Details | ||
| Research Site | Seoul | 06591 | South Korea | Details | ||
| Research Site | Seville | 41071 | Spain | Details | ||
| Research Site | Valencia | 46015 | Spain | Details |